We are live on ! Find out more
SA

Sovran Advisors Portfolio holdings

AUM $1.34B
1-Year Est. Return 21.63%
This Fund
S&P 500
This Quarter Est. Return
+8.46%
1 Year Est. Return
+21.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.13B
AUM Growth
+$177M
Cap. Flow
+$99.2M
Cap. Flow %
8.76%
Top 10 Hldgs %
19.04%
Holding
555
New
69
Increased
253
Reduced
186
Closed
36

Sector Composition

Rank Sector Weight
1 Miscellaneous 71.99%
2 Technology 10.61%
3 Healthcare 3.62%
4 Financials 3.32%
5 Consumer Discretionary 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UFEB icon
551
Innovator US Equity Ultra Buffer ETF February
UFEB
$232M
-7,414
Closed -$255K
UNP icon
552
Union Pacific
UNP
$183B
-1,003
Closed -$237K
URA icon
553
Global X Uranium ETF
URA
$6.39B
-5,406
Closed -$200K
XMLV icon
554
Invesco S&P MidCap Low Volatility ETF
XMLV
$739M
-4,046
Closed -$251K
XSLV icon
555
Invesco S&P SmallCap Low Volatility ETF
XSLV
$245M
-5,314
Closed -$246K

Similar funds

Sovran Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Sovran Advisors held 555 positions worth $1.13B, up 19% from $954M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Sovran Advisors deployed $99.2M of net new capital in Q3 2025, opening 69 new positions and adding to 253 existing holdings. Its largest new stake was BitMine Immersion Technologies: 160,057 shares worth $7.13M.

By sector, the portfolio is most concentrated in Miscellaneous at 72% of assets, down from 73% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $8.35M trimmed.

  • Sovran Advisors's largest Q3 2025 buy was BitMine Immersion Technologies: 160,057 shares worth $7.13M.
  • Sovran Advisors added most to BlackRock US Equity Factor Rotation ETF in Q3 2025, an estimated $4.63M increase.
  • Sovran Advisors's biggest Q3 2025 reduction was Ionis Pharmaceuticals, cutting an estimated $8.35M.
  • Sovran Advisors fully exited Summit Therapeutics in Q3 2025, selling an estimated $3.45M.
  • Sovran Advisors's ten largest holdings make up 19% of its $1.13B portfolio in Q3 2025.
  • Sovran Advisors opened 69 new positions and closed 36 in Q3 2025.
  • Sovran Advisors's portfolio value rose 19% quarter-over-quarter to $1.13B.

Based on Sovran Advisors's 13F filing for Q3 2025, filed 31 Oct 2025.